跳至主要内容
临床试验/NCT04342585
NCT04342585已完成3 期

Randomised Controlled Trial Comparing Vaginal Pessary and Progestogen as an Intervention in Twin Pregnancy With Short Cervical Length to Prevent Spontaneous Preterm Birth

National University of Malaysia1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2019年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
142
试验地点
1
主要终点
Spontaneous preterm birth

研究概览

简要总结

A randomized clinical trial comparing vaginal progestogen and vaginal pessary as an intervention for twin pregnancies with short cervical length.

详细描述

This is a randomized controlled trial to compare women with twin pregnancies and diagnosed with asymptomatic short cervical length. Two types of interventions will be compared i.e vaginal progestogen and vaginal pessary.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • all twin pregnancies
  • cervical length less than 30mm

排除标准

  • Twin to twin transfusion syndrome
  • Stillbirth
  • congenital anomaly in one of the fetuses
  • previous cervical trauma or surgery
  • cervical cerclage in current pregnancy
  • premature labour with or without rupture of membranes
  • severe vaginal discharge
  • acute vaginitis or cervicitis

研究组 & 干预措施

Vaginal progestogen

Active Comparator

200mg of vaginal progestogen will be inserted before bedtime every day from time of recruitment until 34 weeks gestation.

干预措施: Micronised vaginal progesterone (Drug)

Vaginal pessary

Active Comparator

Vaginal pessary with an internal diameter size of 32 or 35 mm will be inserted at the time of recruitment and kept until 34 weeks gestation.

干预措施: Vaginal pessary (Device)

结局指标

主要结局

Spontaneous preterm birth

时间窗: Through study completion up to 37 weeks

Mean gestational age at delivery in weeks

次要结局

  • Maternal age(Pre-intervention)
  • Race(Pre-intervention)
  • Maternal body mass index(Pre-intervention)
  • Parity(Pre-intervention)
  • Type of twin pregnancy(Pre-intervention)
  • Type of conception(Pre-intervention)
  • Gestational age at recruitment(Pre-intervention)
  • Gestational age at commencement of treatment(Pre-intervention)
  • Cervical length before commencement of treatment(Pre-intervention)
  • Vaginal infection(Pre-intervention)
  • Previous miscarriages(Pre-intervention)
  • Pre-existing medical disorders(Pre-intervention)
  • Previous spontaneous preterm birth(Pre-intervention)
  • Antenatal complications(Through study completion up to 37 weeks)
  • Fetal complications(Through study completion up to 37 weeks)
  • Mode of delivery(Through study completion up to 37 weeks)
  • Intrapartum complications(Throughout labour up to delivery of the neonate)
  • Postpartum complications(Through delivery of neonate up to 42 days after delivery)
  • Total blood loss(Through delivery of neonate up to 42 days after delivery)
  • Birth weight(Immediately after birth of neonate)
  • Neonatal complications(Immediately after birth up to 30 days)
  • Apgar score(Immediately after birth of neonate)
  • Anthropometry assessment of neonates(Immediately after birth of neonate)
  • Duration in neonatal intensive care unit(Through neonatal intensive care unit stay up to discharge (approximately 30 days))
  • Neonatal intensive care unit admission(Immediately after birth of neonate up to discharge (approximately 30 days))

研究者

发起方
National University of Malaysia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rahana Abd Rahman

Co-primary investigator

National University of Malaysia

研究点 (1)

Loading locations...

相似试验